FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Ocular Implant topics
Ocular Implant
Intraocular
Anterior Chamber
Ocular Implants
Intraocular Pressure
Anterior Chamber Of The Eye
Implantation
Biodegradable
Drug Delivery System
Bevacizumab
Medical Device
Multiple Stents
Aqueous Humor
Visualization
Instruments

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Ocular Implant patents



      
           
This page is updated frequently with new Ocular Implant-related patent applications. Subscribe to the Ocular Implant RSS feed to automatically get the update: related Ocular RSS feeds. RSS updates for this page: Ocular Implant RSS RSS


Retinal prosthesis

Retinal prosthesis

Retinal prosthesis

Methods and apparatus for delivering ocular implants into the eye

Date/App# patent app List of recent Ocular Implant-related patents
11/20/14
20140343476
 Ocular implant with intraocular fluid pressure regulation patent thumbnailOcular implant with intraocular fluid pressure regulation
An ocular implant comprising a shunt and a fluid absorbing conduit for reducing intraocular pressure, and optionally comprising a biodegradable ring.. .
11/20/14
20140341966
 Steroid-containing sustained release intraocular implants and related methods patent thumbnailSteroid-containing sustained release intraocular implants and related methods
Biocompatible intraocular implant systems are formulated for discontinuous or intermittent release of therapeutic levels of a therapeutic agent (such as a steroid) to minimize development of side effects associated with continuous or long term use of such agent. The implant system may comprise one or more implant, and preferably, although not necessarily, also contains an auxiliary agent having an activity effective to lessen at least one side effect associated with said therapeutic agent compared to the use of an otherwise identical implant system lacking said auxiliary agent.
11/13/14
20140336724
 Retinal prosthesis patent thumbnailRetinal prosthesis
The present invention relates to retinal prostheses, and in particular to the transfer of electrical power and data from outside of the human body to such a prosthesis. The retinal prosthesis comprises: a retinal electrode array implanted in the eye to stimulate the retina.
10/30/14
20140323944
 Methods and apparatus for delivering ocular implants into the eye patent thumbnailMethods and apparatus for delivering ocular implants into the eye
A method of deploying an ocular implant into schlemm's canal of a human eye including the following steps: inserting a distal tip of a delivery tool within an anterior chamber of the eye through trabecular meshwork of the eye into schlemm's canal of the eye; and advancing an ocular implant through a curved portion and a distal opening of the delivery tool to place a body portion of the ocular implant in schlemm's canal and an inlet portion of the ocular implant in the anterior chamber.. .
10/30/14
20140322295
 Steroid-containing sustained release intraocular implants and related methods patent thumbnailSteroid-containing sustained release intraocular implants and related methods
Biocompatible intraocular implants include a steroid and an auxiliary agent, where the auxiliary agent is present in an amount sufficient to lessen the severity of at least one side effect compared to the use of an otherwise identical implant lacking said auxiliary agent. The steroid and the auxiliary agent may be present on the same intraocular implant or on different implants.
10/23/14
20140316009
 Intraocular pressure reduction with intracameral bimatoprost implants patent thumbnailIntraocular pressure reduction with intracameral bimatoprost implants
The present invention provides a method of treating an ocular condition in an eye of a patient, comprising the step of placing a biodegradable intraocular implant in an eye of the patient, the implant comprising a prostamide and a biodegradable polymer matrix that releases drug at a rate effective to sustain release of an amount of the prostamide from the implant to provide an amount of the prostamide effective to prevent or reduce a symptom of an ocular condition of the eye, wherein said ocular condition is elevated iop and said implant is placed in an intracameral location to dilate the outflow channels of the eye emanating from schlemm's canal.. .
09/25/14
20140288645
 Cell migration inhibition system patent thumbnailCell migration inhibition system
Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye..
09/18/14
20140277432
 In situ adjustable optical mask patent thumbnailIn situ adjustable optical mask
Implantable corneal and intraocular implants such as a mask are provided. The mask can improve the vision of a patient, such as by being configured to increase the depth of focus of an eye of a patient.
09/18/14
20140271780
 Prostamide-containing intraocular implant patent thumbnailProstamide-containing intraocular implant
Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.. .
09/18/14
20140264981
 Process for manufacturing an intraocular lens with an embedded mask patent thumbnailProcess for manufacturing an intraocular lens with an embedded mask
Intraocular implants and methods of making intraocular implants are provided. The intraocular implant can include a mask adapted to increase depth of focus.
09/04/14
20140249624
Intraoperative estimation of intraocular lens power
Apparatus for performing intraocular implant surgery, including surgical apparatus for performing intraocular implant surgery, an autorefraction device associated with the surgical apparatus, wherein the autorefraction device is configured to perform autorefraction on the aphakic eye to provide one or more aphakic refraction measurements, and a processor connected to the autorefraction device, wherein the processor is configured to process the aphakic refraction measurements and provide the user of the apparatus with information regarding the power of the intraocular lens.. .
09/04/14
20140249463
Ocular implant system and method
A method of treating glaucoma in a human eye by inserting a distal exit port of a cannula at least partially into schlemm's canal of the eye; delivering a dye through the cannula into schlemm's canal; identifying obstructions within schlemm's canal; and delivering an ocular implant through the cannula into schlemm's canal.. .
09/04/14
20140249123
Extended release biodegradable ocular implants
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer..
08/21/14
20140236270
Method and ocular implant for transmission of nerve-stimulation light
An improved prosthesis and method for stimulating vision nerves to obtain a vision sensation that is useful for the patient that has lost vision due to age-related macular degeneration (amd) and retinitis pigmentosa (rp) and other diseases. The present invention utilizes infrared light to cause action potentials in the retinal nerves similar to those which result from rods and cones stimulated by visible light in healthy retinas.
08/21/14
20140234390
Sustained drug delivery implant
Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.. .
08/21/14
20140234389
Sustained drug delivery implant
Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.. .
07/31/14
20140214161
Ocular implants with asymmetric flexibility
An ocular implant having an inlet portion and a schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the schlemm's canal portion being arranged and configured to be disposed within schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.. .
07/31/14
20140213958
Schlemm's canal devices and method for improving fluid flow
This disclosure relates generally to methods and devices for an ocular implant which can be positioned in the schlemm's canal of a patient's eye for improving fluid flow, such as aqueous fluid, through the eye. The ocular implant can have a variety of shapes and sizes which can allow the ocular implant to be implanted in the schlemm's canal for applying a force, including a predetermined force, along a part of the schlemm's canal.
07/24/14
20140205649
Solvent cast film sustained release latanoprost implant
The present invention provides a sustained release latanoprost implant in the form of a thin film comprising latanoprost incorporated in a biodegradable polymer matrix. Preferably, said implant is an intraocular implant comprising a thin film comprising latanoprost incorporated in a biodegradable polymer matrix wherein said implant is configured as a disc or a rolled film that can be inserted into the eye and unrolls to provide a film having a high surface area to volume ratio..
07/17/14
20140199366
Sustained release intraocular implants and methods for treating ocular neuropathies
Biocompatible intraocular implants include a beta adrenergic receptor antagonist and a polymer associated with the beta adrenergic receptor antagonist to facilitate release of the beta adrenergic receptor antagonist into an eye for an extended period of time. The beta adrenergic receptor antagonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers.
07/03/14
20140187637
Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof
The present invention provides tromethamine salt of 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoic acid in crystalline and amorphous form. This compound is may also be referred to as “tromethamine salt of bimatoprost acid.” the invention crystalline form is useful for solid ocular implant or topical formulations, utilized in the treatment of various ocular conditions, such as, for example, ocular hypertension..
07/03/14
20140187636
Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof
The invention provides new crystalline forms of 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoic acid. This compound is commonly referred to as “bimatoprost acid.” the novel crystalline forms are designated forms i, ii, and iii.
06/19/14
20140172090
Osmotically actuated fluidic valve
An implantable fluidic valve actuated by osmotic pressure gradient and methods of operating it are provided. The valve includes: an input fluid channel; an output fluid channel in fluid communication with the input fluid channel at an aperture; and a semi-permeable membrane forming a portion of a sealed chamber.
06/19/14
20140171777
Systems and methods for priming an intraocular pressure sensor in an intraocular implant
An iop monitoring device for implantation in an eye of a patient may include a first tube having a first opening, the first tube being configured to extend into the anterior chamber. An intraocular pressure sensing (iop) device for implantation in an eye of a patient may include a pressure sensor, a pressure sensor cap, and a tube coupled to a chamber inlet.
06/05/14
20140155842
Apparatus and methods for implanting particulate ocular implants
Apparatus and methods for implanting ocular implants in eyes are provided which include a bent cannula having a lumen extending therethrough, the lumen having a length and a diameter and being configured to receive an ocular implant. The ocular implant is made up of a plurality of substantially uniformly sized particles, preferably a plurality of uniformly sized microspheres, arranged in a one-by-one array along the length of the lumen.
06/05/14
20140155805
Delivery system for ocular implant
A delivery system is disclosed which can be used to deliver an ocular implant into a target location within the eye via an ab interno procedure. In some embodiments, the implant can provide fluid communication between the anterior chamber and the suprachoroidal or supraciliary space while in an implanted state.
06/05/14
20140155803
Ocular implant with fluid outflow pathways having microporous membranes
Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications.
05/22/14
20140142378
Ocular implant delivery systems and methods
Described herein are delivery devices and methods of using the devices for delivering an ocular implant into a suprachoroidal space without use of a goniolens. The delivery device includes a handle including a channel extending from a proximal end of the handle to a distal end of the handle, an applier coupled to the handle, the applier including a blunt distal tip and an elongate, flexible wire insertable through a fluid channel of an ocular implant, and a fiber optic image bundle reversibly inserted through the channel such that the fiber optic image bundle extends to a region proximal to the blunt distal tip of the applier..
05/15/14
20140135916
Flow promoting ocular implant
Disclosed are devices, methods and systems for treatment of eye disease, including open angle glaucoma and narrow angle glaucoma. Implants are described herein that create a directed flow field, such as between the anterior chamber and either the supraciliary space or suprachoroidal space.
05/15/14
20140132922
Optical angular measurement system for ophthalmic applications and method for positioning of a toric intraocular lens with increased accuracy
An ophthalmic system for use in performing angular measurements in relation to a patient's eye. The ophthalmic system can include an optical angular measurement device that can provide angular indicia by, for example, projecting an image of an angular measurement reticle onto a patient's eye or by superimposing an image of an angular measurement reticle onto an image of the patient's eye.
05/15/14
20140131905
Process for manufacturing an intraocular lens
Intraocular implants and methods of making intraocular implants are provided. The intraocular implant can include a mask adapted to increase depth of focus.
05/01/14
20140121584
Delivering ocular implants into the eye
A method of deploying an ocular implant into schlemm's canal of an eye. The method includes the steps of inserting a distal end of a cannula through a cornea of the eye and into an anterior chamber of the eye, the cannula having a distal opening extending from the distal end and through a side wall; placing the distal opening of the cannula into fluid communication with schlemm's canal; advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the cannula distal opening.
04/24/14
20140114323
Ocular implant insertion apparatus and methods
An exemplary ocular implant insertion system includes a case and a preloaded ocular implant insertion apparatus. The apparatus includes first and second movable structures that move the ocular implant in a predetermined sequence.
04/24/14
20140114229
Ocular implants for delivery into the eye
An ocular implant adapted to reside at least partially in a portion of schlemm's canal of an eye. The implant includes a spine extending along a longitudinal axis of the implant, a plurality of curved supports extending from the spine, each support comprising a first end extending from a first location on a first side of the spine and a second end extending from a second location on a second side of the spine, the second location being proximal to the first location, so that each support forms a portion of a helix, the spine and supports defining a volume having a maximum width perpendicular to the longitudinal axis between 0.005 inches and 0.04 inches, the ocular implant being configured to bend preferentially in a preferential bending plane..
04/17/14
20140107556
Ocular implant with shape change capabilities
Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications.
03/20/14
20140081195
Expanding ocular implant devices and methods
Disclosed herein are devices and methods related to implants for treating one or more physiological conditions of the eye. Some embodiments disclosed herein include an expandable ocular implant for implanting in an eye.
03/06/14
20140066831
Ocular implant with stiffness qualities, methods of implantation and system
Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway.
02/13/14
20140046439
Implantable mems device and method
An implantable mems package for the treatment of an ocular condition is provided. The mems package includes an outer portion; an active portion attached to the outer portion, the active portion including a fluid regulating element having a moving element; and a fluidic channel at an interface of the outer portion and the active portion.
02/06/14
20140039510
Tps tools and methods for the surgical placement of intraocular implants
Provided herein are alignment systems, computer-implemented systems and methods utilizing the same for planning an optimal surgical implantation of asymmetric optics into one or both eyes of a patient and/or correcting astigmatism thereof. The methods generally comprise obtaining reference data comprising the surgical procedure plan, the reference image and the corneal topographic measurements for the patient's eye, determining an optimal placement angle of an optical zone on the cornea from the reference data and placing the asymmetric optic into the eye to match the determined optimal placement angle.
02/06/14
20140038972
Alpha-2 agonist polymeric drug delivery systems
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers.
02/06/14
20140035184
Extended release biodegradable ocular implants
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer..
01/30/14
20140031833
Interocular injector
An intraocular injector includes a syringe body having open-ended cone disposed in one end thereof along with a piston disposed in the body. A transparent implant holder having a lumen therein is aligned with an open-ended cone, a needle include a proximal end and a distal end with a bevel disposed on the distal end of the needle.
01/30/14
20140031408
Biodegradable intravitreal tyrosine kinase implants
Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol.
01/09/14
20140012279
Ocular implant applier and methods of use
Described herein is a delivery device and methods for delivering an ocular implant into an eye. The delivery device includes a proximal handle portion; a distal delivery portion coupled to a distal end of the handle portion and configured to releasably hold an ocular implant and includes a sheath positioned axially over a guidewire; and a metering system configured to provide visual guidance regarding depth of advancement of an implant positioned on the guidewire into an anatomic region of the eye.
01/09/14
20140012177
Ocular implant with therapeutic agents and methods thereof
Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye.
01/09/14
20140010823
Method for determining optimum intraocular locations for drug delivery systems
A method for determining the optimum location for placement of an intraocular implant containing used to treat an ocular condition, particularly implants comprised of a biodegradable polymer and a therapeutic agent for the treatment of retinal tissue.. .
01/02/14
20140005782
Intraocular lens with accommodation
An accommodating intraocular implant apparatus is disclosed for implantation in the human eye. The apparatus includes an optic portion having a periphery and an optic axis, said optic portion lying substantially within an optic plane transverse to said optic axis; at least one flexible haptic extending from a point on or near the periphery of the optic portion; at least one flexible haptic having a fixation anchor portion distal to the periphery of the optic portion; and at least one flexible haptic having a centering anchor portion.
12/26/13
20130345808
Intraocular implants and related kits and methods
Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within schlemm's canal and that may restore or maintain at least partial patency of the canal without substantially interfering with transmural or transluminal fluid flow across the canal.


Popular terms: [SEARCH]

Ocular Implant topics: Ocular Implant, Intraocular, Anterior Chamber, Ocular Implants, Intraocular Pressure, Anterior Chamber Of The Eye, Implantation, Biodegradable, Drug Delivery System, Bevacizumab, Medical Device, Multiple Stents, Aqueous Humor, Visualization, Instruments

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Ocular Implant for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ocular Implant with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



1.0481

3569

1 - 1 - 71